Global /South Korea /Healthcare /Biotechnology /144510

GC Cell Corp.

144510

• KRX: 144510 • Delayed

23,750KRW -2.7%

15.22 USD

As of 6 June 2026, GC Cell Corp. has a market cap of $232.84M USD, ranking #20132 globally and #738 in South Korea. It ranks #1811 in the Healthcare sector, and #349 in the Biotechnology industry.

Global Rank

20132

Country Rank

738

Sector Rank

1811

Industry Rank

349

Key Stats

Market Cap

$232.84MUSD

356.89B KRW

Enterprise Value

$281.83MUSD

439.64B KRW

Revenue (TTM)

$107.99MUSD

165.52B KRW

EBITDA (TTM)

$1.08MUSD

1.68B KRW

Net Income (TTM)

-$178.01MUSD

-272.86B KRW

EBITDA Margin

Profit Margin

-165%

PS Ratio

2.2

PB Ratio

1.9

EV/EBITDA

261.7

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Biotechnology

CEO

Jai-Wang Kim open_in_new

Employees

698

Founded

2011

Website

gccell.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.7%	-2.4%	-4.1%	-6.7%	6.6%	-1.8%	15%	-43%	-79%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	144510 (주)지씨셀 ISIN: KR7144510005 Shares Out.: Shares Outstanding: 15.027M¹ Shares Float: 7.884M² TV: TradingView: KRX: 144510 SA: Stock Analysis: KRX: 144510 YF: Yahoo Finance: 144510.KS GF: Google Finance: KRX: 144510 BA: Barron's: 144510 MS: Morningstar: XKRX: 144510	23,750 KRW	TV: TradingView: KRX: 144510 SA: Stock Analysis: KRX: 144510 YF: Yahoo Finance: 144510.KS GF: Google Finance: KRX: 144510 BA: Barron's: 144510 MS: Morningstar: XKRX: 144510

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About GC Cell Corp.

GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin-si, South Korea.

Similar Companies

Industry: Biotechnology (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 19K%	35.5	South Korea
Celltrion, Inc. KRX: 068270	$27.89B 42.76T KRW 12K%	43.8	South Korea
ALTEOGEN Inc. KRX: 196170	$13.27B 20.33T KRW 6K%	146.6	South Korea
HLB Co., Ltd. KRX: 028300	$5.46B 8.37T KRW 2K%	-	South Korea
Peptron, Inc. KRX: 087010	$3.96B 6.07T KRW 2K%	-	South Korea
SK bioscience Co.,Ltd. KRX: 302440	$2.23B 3.42T KRW 860%	-	South Korea

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 78K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 69K%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 21K%	39.9	Netherlands
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 18K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 18K%	37.2	Switzerland
Natera, Inc. NASDAQ: NTRA	$27.6B 12K%	-	United States

chevron_leftBack